Latest filing published 18 May 2021 for Infinity Pharmaceuticals, INC., €3,809.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Norman C. Selby is a declared insider at 2 companies (board member); the most frequent names are Infinity Pharmaceuticals, Inc. and Millennium Pharmaceuticals Inc. Over a trading history stretching from 9 May 2008 to 14 May 2021, the count stands at 8 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 18 May 2021, reports an option exercise of €3,809 in Infinity Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration